Table 3.
Past Reports of SLE-associated AAC Conservatively Treated with Corticosteroid.
| Cases (Reference) | Number of patients | Age | Sex | Other collagen diseases complicated with SLE | Drugs combined with corticosteroids | Outcomes (number of patients) |
|---|---|---|---|---|---|---|
| Case 1 (34) | 1 | 39 | F | SjS | None | Success |
| Case 2 (47) | 1 | 10 | M | Not mentioned | CTRX, MTZ | Cholecystectomy |
| Case 3 (35) | 1 | 30 | F | None | AZA, MMF | Success |
| Case 4 (36) | 1 | 70 | F | Not mentioned | CPA | Success |
| Case 5 (37) | 1 | 32 | F | Not mentioned | None | Success |
| Cases 6-17 (38) | 12 | 34.7±11.0 | F | Not mentioned | MFLX | Success (11), Cholecystectomy (1) |
| Our case 2019 | 1 | 69 | F | RA | HCQ, CyA, AZA | Success |
AAC: acute acalculous cholecystitis, SLE: systemic lupus erythematosus, F: female, M: male, SjS: Sjögren’s syndrome, RA: rheumatoid arthritis, CTRX: ceftriaxone, MTZ: metronidazole, AZA: azathioprine, MMF: mycophenolate mofetil, CPA: cyclophosphamide, MFLX: moxifloxacin, HCQ: hydroxychloroquine, CyA: cyclosporin A